Research Topics
| E RitzSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Lipid changes and statins in chronic renal insufficiencyEberhard Ritz
Ruperto Carola University Heidelberg, Heidelberg, Germany
J Am Soc Nephrol 17:S226-30. 2006..e. interference with proximal tubular reabsorption of protein) meanwhile has been well documented...
Phosphate additives in food--a health riskEberhard Ritz
Nierenzentrum Heidelberg, 69120 Heidelberg, Germany
Dtsch Arztebl Int 109:49-55. 2012..Therefore, phosphate additives in food are a matter of concern, and their potential impact on health may well have been underappreciated...
Renal protection in diabetes: lessons from ONTARGETEberhard Ritz
Universitat Erlangen, Medizinische Klinik IV, Erlangen, Germany
Cardiovasc Diabetol 9:60. 2010....
Renal dysfunction: a novel indicator and potential promoter of cardiovascular riskEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Clin Med 3:357-60. 2003..Great progress has been made in providing algorithms to detect patients at risk and to identify interventions to reduce the risk...
[Sodium at the crossroads of history and culture]E Ritz
Ruperto Carola Universität Heidelberg, Germany
Nephrol Ther 3:S84-90. 2007..It broaches the important question of "salt hunger" of the vital role of salt in past times, a costly substance because it was indispensable, and the basis of a tax (the salt tax) which underlay the French Revolution...
Hyperphosphatemia in renal failureEberhard Ritz
Department Internal Medicine and Pathology, Ruperto Carola University, Heidelberg, Germany
Blood Purif 23:6-9. 2005..Currently sevelamer and lanthanum carbonate have been introduced and trivalent iron preparations are under development...
Hemodialysis--from early days to tomorrowEberhard Ritz
Department Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Contrib Nephrol 149:1-9. 2005..Elucidating and correcting the cardiovascular risk is the most important challenge to clinical nephrology today...
Lifestyle modification and progressive renal failureEberhard Ritz
Nierenzentrum Department Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Nephrology (Carlton) 10:387-92. 2005..Alcohol consumption, according to some preliminary information, has a bimodal relationship to cardiovascular risk and progression, with moderate consumption being protective...
Diabetic nephropathy and anaemiaE Ritz
Department Internal Medicine, Ruperto Carola University Heidelberg, Germany
Eur J Clin Invest 35:66-74. 2005....
Total cardiovascular risk managementEberhard Ritz
Division of Nephrology, Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Am J Cardiol 100:53J-60J. 2007..Clearly, isolated treatment of hypertension is no longer sufficient; risk factors and target organ damage need to be actively searched for and treated if long-term cardiovascular health is to be improved...
Obesity and chronic kidney diseaseEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Semin Nephrol 29:504-11. 2009..This article summarizes the current hypotheses that link visceral obesity and kidney malfunction and provides information on the epidemiology and renal pathology resulting from visceral obesity...
Compounds in development to combat hyperphosphataemiaE Ritz
Medizinische Klinik I der Universitat Heidelberg, Sektion Nephrologie, Bergheimerstr 56a, 69115 Heidelberg, Germany
Expert Opin Investig Drugs 10:2185-90. 2001....
Salt--a potential 'uremic toxin'?Eberhard Ritz
Department of Internal Medicine, Ruperto Carola University Heidelberg, Heidelberg, Germany
Blood Purif 24:63-6. 2006..However, it is possible, and indeed likely, that sodium plays an adverse role in the genesis of target organ damage in terminal renal failure...
Managing anaemia and diabetes: a future challenge for nephrologistsEberhard Ritz
University of Heidelberg, Heidelberg, Germany
Nephrol Dial Transplant 20:vi21-5. 2005..The Individualised Risk-profiling In DIabEtes Mellitus (IRIDIEM) study will provide evidence-based guidance in risk factor management, by assessing the efficacy of individualized interventions...
Do beta-blockers combined with RAS inhibitors make sense after all to protect against renal injury?Eberhard Ritz
Nierenzentrum, Im Neuenheimer Feld 162, D69120 Heidelberg, Germany
Curr Hypertens Rep 9:409-14. 2007..Several points argue for ancillary treatment with beta-blockers: in CKD often four or more different antihypertensive drugs are required and cardiac indications are frequent...
Compelling drug indications in diabetic and nondiabetic nephropathyEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Bergheimerstrasse 58, D69115 Heidelberg, Germany
Curr Hypertens Rep 6:293-9. 2004....
Lipid abnormalities and cardiovascular risk in renal diseaseEberhard Ritz
Department of Internal Medicine, Division of Nephrology, University of Heidelberg, Heidelberg, Germany
J Am Soc Nephrol 19:1065-70. 2008..Admittedly, in the absence of definite evidence in dialysis patients, we still conclude that the administration of statins is appropriate in patients with manifest coronary disease...
[Historical roles of salt]E Ritz
Medizinische Universitatsklinik Heidelberg
Dtsch Med Wochenschr 129:2780-3. 2004..In the past salt was essential to preserve food. The past importance of salt as a commodity can well be compared with that of oil today. These and further historical aspects of the role of salt are briefly dealt with in this article...
Kidney and hypertension-causes. Update 2003Eberhard Ritz
Department of Internal Medicine, Heidelberg, Germany
Herz 28:663-7. 2003..Fifth, the pulse pressure profile is altered as a consequence of premature and accelerated aging causing stiffening of the aorta. Knowledge of these pathomechanisms is important for selection of appropriate antihypertensive treatment...
Atherosclerosis in dialyzed patientsEberhard Ritz
University of Heidelberg, Department of Nephrology, Heidelberg, Germany
Blood Purif 22:28-37. 2004....
The challenge of sudden death in dialysis patientsEberhard Ritz
Department of Internal Medicine, Division of Nephrology, University of Heidelberg, Germany
Clin J Am Soc Nephrol 3:920-9. 2008
Disorders of phosphate metabolism--pathomechanisms and management of hypophosphataemic disordersEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Bergheimer Str 58, Heidelberg D 69115, Germany
Best Pract Res Clin Endocrinol Metab 17:547-58. 2003..In patients with gastrointestinal intolerance to phosphate or with severely symptomatic bone disease, prolonged intravenous administration of Pi is necessary...
Managing mineral balance in end-stage renal diseaseEberhard Ritz
, Sektion Nephrologie, Bergheimer Strasse 56a, D-69115 Heidelberg, Germany
Nephrol Dial Transplant 19:i1-3. 2004
Can we ameliorate quality of life in chronic kidney disease? The nephrologist's point of viewEberhard Ritz
Department of Internal Medicine Nierenzentrum, Ruperto Carola University, Im Neuenheimer Feld 162, Heidelberg, Germany
J Nephrol 21:S9-11. 2008..Chronic dialysis treatment creates a particular "microcosmos" in which interpersonal relations and psychological problems carry particular weight...
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetesRitz Eberhard
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Ann Med 34:507-13. 2002..This review provides an in-depth discussion of the results of these studies and provides recommendations for patient management...
Salt restriction in kidney disease--a missed therapeutic opportunity?Eberhard Ritz
Department of Internal Medicine, Ruperto Carola University of Heidelberg, Nierenzentrum, Im Neuenheimer Feld 162, 69120, Heidelberg, Germany
Pediatr Nephrol 24:9-17. 2009....
Renal dysfunction as a cardiovascular risk factorEberhard Ritz
Department of Internal Medicine, University of Heidelberg, Bergheimer Strasse 58, Germany
Curr Hypertens Rep 4:365-8. 2002..Epidemiologic information suggests that renal and cardiovascular outcome run parallel in this segment of the population...
A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. IntroductionEberhard Ritz
Division of Nephrology, Department of Internal Medicine, Ruperto Carola University of Heidelberg, Germany
Nat Clin Pract Cardiovasc Med 5:S1-2. 2008
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) StudyEberhard Ritz
Department of Internal Medicine, University of Heidelberg Medical Clinic I, University Hospital Mannheim, Germany
Am J Kidney Dis 49:194-207. 2007..The Anemia CORrection in Diabetes (ACORD) Study aimed to investigate the effect of anemia correction on cardiac structure, function, and outcomes in patients with diabetes with anemia and early diabetic nephropathy...
[Diuretics for the treatment of edema]Eberhard Ritz
, Sektion Nephrologie
Pharm Unserer Zeit 35:342-5. 2006
Anemia and diabetic nephropathyEberhard Ritz
Nierenzentrum, Medizinische Universitatsklinik Heidelberg, Im Neuemheimer Feld 162, D 69120 Heidelberg, Germany
Curr Diab Rep 6:469-72. 2006..A major cause is an inappropriate erythropoietin response to anemia, often accompanied by iron deficiency and therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers...
Hypertension and antihypertensive treatment of diabetic nephropathyEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Nat Clin Pract Nephrol 2:562-7. 2006..In addition to blood pressure, proteinuria is a treatment target and should be reduced to below 1 g/24 h...
Prenatal programming-effects on blood pressure and renal functionEberhard Ritz
Division of Nephrology, Department of Internal Medicine, University of Heidelberg, Heidelberg 69100, Germany
Nat Rev Nephrol 7:137-44. 2011..This Review outlines the concept of prenatal programming and, in particular, describes its role in kidney disease and hypertension...
Intestinal-renal syndrome: mirage or reality?Eberhard Ritz
Nierenzentrum, Im Neuenheimer Feld 162, Heidelberg, Germany
Blood Purif 31:70-6. 2011....
[Smoking -- the futile fight against the vice. A historical perspective]E Ritz
, Heidelberg
Dtsch Med Wochenschr 130:2947-51. 2005
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensionsE Ritz
Department of Internal Medicine, Ruperto Carola University Heidelberg, Germany
Am J Kidney Dis 34:795-808. 1999..It is argued that the challenge for the future will be better patient management in earlier phases of diabetic nephropathy to attenuate or prevent progression, as well as cardiovascular complications...
Is there an obesity-metabolic syndrome related glomerulopathy?Eberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Curr Opin Nephrol Hypertens 20:44-9. 2011..This form of FSGS represents the tip of an iceberg: a much broader spectrum of renal malfunction is linked to visceral obesity, which is closely connected to, but not completely identical with, the concept of 'metabolic syndrome'...
Hypertension and kidney diseaseE Ritz
Nierenzentrum, Heidelberg, Germany
Clin Nephrol 74:S39-43. 2010..The possible role of non muscular heavy chain type II isoform A protein which is associated with non diabetic chronic kidney disease in subjects of African ancestry remains to be determined...
Role of sodium intake in the progression of chronic kidney diseaseEberhard Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
J Ren Nutr 19:61-2. 2009..The effect of salt restriction cannot be reproduced by treatment with diuretics. Inappropriate increase of intrarenal angiotensin II and increased reactive oxygen species are the major culprits responsible for salt-related renal damage...
Drug of choice in the management of hypertension in diabetes and diabetic nephropathy: angiotensin-converting enzyme inhibitorsEberhard Ritz
Division of Nephrology, Department of Internal Medicine, Nierenzentrum, Heidelberg, Germany
J Clin Hypertens (Greenwich) 13:285-9. 2011..In proteinuric diabetic nephropathy, renin-angiotensin system blockade is clearly indicated, but monotherapy is practically always insufficient to achieve target blood pressure values...
Is the renal risk of adults determined in utero?E Ritz
Department of Internal Medicine, Division of Nephrology, Ruprecht Karl University of Heidelberg, Heidelberg, Germany
Kidney Int 72:667-8. 2007..The results of the prospective study of Verburg et al., sequentially measuring the growth of fetuses and the volume of their kidneys in a large population-based sample, identify some determinants of impaired growth of fetal kidneys...
[The kidney in the Bible]E Ritz
,
Dtsch Med Wochenschr 131:2916-9. 2006
Cardiovascular problems on hemodialysis: current deficits and potential improvementEberhard Ritz
Department Internal Medicine, Nierenzentrum, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany
Clin J Am Soc Nephrol 4:S71-8. 2009..Classical risk factors cannot fully explain the magnitude of the risk. This article addresses some nontraditional approaches to deal with the excessive cardiovascular risk for patients who are on hemodialysis...
Renal research in 19th century GermanyEberhard Ritz
Department of Internal Medicine, Division of Nephrology, University Heidelberg, Germany
Am J Kidney Dis 55:1121-9. 2010....
Heart and kidney: fatal twins?Eberhard Ritz
Department of Nephrology, Ruprecht Karl University, Heidelberg, Germany
Am J Med 119:S31-9. 2006..Still to be resolved, however, is the optimal dosage; several recent studies indicate that the dosage required for maximal blood pressure reduction is insufficient to provide maximal renoprotection...
Salt and hypertensionEberhard Ritz
Department of Internal Medicine, Division Nephrology, Nierenzentrum, Heidelberg, Germany
Nephrology (Carlton) 15:49-52. 2010..Current salt intake is too high. Current evidence documents that salt is crucial to the genesis of hypertension...
Blood pressure in diabetic nephropathy--current controversiesE Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
J Intern Med 249:215-23. 2001..Apart from blood pressure, proteinuria should be monitored and dosing of ACE inhibitors should be guided, also by reduction of protein excretion...
Aldosterone in uremia - beyond blood pressureEberhard Ritz
Nierenzentrum, Ruperto Carola University Heidelberg, Heidelberg, Germany
Blood Purif 29:111-3. 2010....
Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritisC Dechow
Division of Nephrology, University of Heidelberg, D-69115, Germany
Am J Physiol Renal Physiol 281:F909-19. 2001..In conclusion, all-trans-RA influences the renal RAS in anti-Thy1.1 nephritis by decreasing ANG II synthesis and receptor expression. The beneficial effect of retinoids may be explained, at least in part, by reduction of RAS activity...
Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic ratsK Amann
Departments of Pathology, Heidelberg, Erlangen, Germany
Kidney Int 58:153-61. 2000....
Retinoic acid reduces glomerular injury in a rat model of glomerular damageJ Wagner
Department of Nephrology, University of Heidelberg, Heidelberg, Germany
J Am Soc Nephrol 11:1479-87. 2000..001). It is concluded that all-trans-RA limits glomerular proliferation, glomerular lesions, and albuminuria in an established model of renal damage. The findings point to retinoids as potential novel modulators of glomerular injury...
Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animalsK Amann
Department of Pathology, University of Heidelberg, Heidelberg, Germany
J Am Soc Nephrol 11:1702-11. 2000..The results support a role of ET-1 in the genesis of left ventricular capillary/myocyte mismatch in uremia...
Antihypertensive therapy in renal patients - benefits and difficultiesV Schwenger
Klinikum der Universitat Heidelberg, Sektion Nephrologie, Heidelberg, Deutschland
Nephron 83:202-13. 1999..Thus it is very important to lower the nighttime blood pressure and to detect nighttime blood pressure increases using ambulatory blood pressure measurements...
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized ratsK Amann
Department of Pathology, University of Heidelberg, Germany
J Am Soc Nephrol 11:1469-78. 2000..In kidneys of SNX rats, indirect evidence was found for increased activity of a reduced number of nerve fibers...
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetesM L Gross
Department of Pathology, University of Heidelberg, Heidelberg, Germany
Diabetologia 47:316-24. 2004..To this end we compared the effects of an ET receptor A blocker (ETA-RB) with that of an ACE-inhibitor (ACE-i) or their combination in rats with Streptozotocin (STZ) diabetes...
Isotretinoin alleviates renal damage in rat chronic glomerulonephritisM Schaier
Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Kidney Int 60:2222-34. 2001..Retinoids may provide a novel therapeutic option for the treatment of glomerulonephritis...
Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cellsV Haxsen
Department of Nephrology, University Hospital, University of Heidelberg, Heidelberg, Germany
Circ Res 88:637-44. 2001..Our findings demonstrate that retinoids are potent inhibitors of the actions of Ang II on VSMCs. The findings support the notion that retinoids may interfere with proliferative vascular disease...
Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetesM L Gross
Department of Pathology, University of Heidelberg, Im Neuenheimer Feld 220 221, 69120 Heidelberg, Germany
Lab Invest 84:452-64. 2004..In contrast, the diabetic SHR/N-cp exhibits marked structural lesions, particularly podocyte damage and mesangial expansion that promise to make it a more suitable model for investigation of diabetic glomerulosclerosis...
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow
Department of Nephrology, University Hospital of Heidelberg, Heidelberg, Germany
Clin Nephrol 72:366-72. 2009....
Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?K Amann
Department of Pathology, University of Heidelberg, Heidelberg, Germany
Nephrol Dial Transplant 15:964-9. 2000..e. capillary/myocyte mismatch in experimental renal failure...
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz
Department of Nephrology, University of Heidelberg, Heidelberg, Germany
Diabetologia 53:49-57. 2010..This may be important because even within the normoalbuminuric range, higher rates of albuminuria are known to be associated with higher renal and cardiovascular risk...
Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertensionD Fliser
Department of Internal Medicine, University of Heidelberg, Germany
Blood Press 2:296-300. 1993....
Renal failure and ACE inhibition: how much is too much?M L Gross
Department Pathology, University of Heidelberg, Im Neuenheimer Feld, 69120 Heidelberg, Germany
Z Kardiol 94:81-6. 2005..Ongoing studies try to define the relative merits of high dose monotherapy (ACE inhibitors or angiotensin receptor blockers) versus a combination therapy of the two...
Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuriaI Lehrke
Department of Nephrology, University of Heidelberg, Germany
J Am Soc Nephrol 12:2321-9. 2001..It is concluded that the increased ET-R(B) and ET-1 mRNA and protein expression observed in animal models of renal disease is also demonstrable among patients with renal disease and high-grade proteinuria...
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser
Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
J Am Soc Nephrol 16:2456-61. 2005..The endogenous NO synthase inhibitor ADMA is significantly associated with progression of nondiabetic kidney diseases. Lowering plasma ADMA concentrations may be a novel therapeutic target to prevent progressive renal impairment...
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) StudyDanilo Fliser
Department of Internal Medicine, Hannover Medical School, Germany
J Am Soc Nephrol 18:2600-8. 2007..In conclusion, FGF23 is a novel independent predictor of progression of renal disease in patients with nondiabetic CKD. Its pathophysiological significance remains to be elucidated...
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indicationsGunter Wolf
Department of Medicine, Division of Nephrology, Osteology, and Rheumatology, University of Hamburg, Hamburg, Germany
Kidney Int 67:799-812. 2005..In our opinion patients with proteinuria >1 g/day despite optimal blood pressure control under RAS-blocking monotherapy are a high-risk group which will presumably benefit from combination therapy...
How should we manage anaemia in patients with diabetes?Ralf Dikow
Department of Nephrology, University of Heidelberg, Germany
Nephrol Dial Transplant 17:67-72. 2002..Further studies are required to determine whether reversal of anaemia has beneficial effects on microvascular and macrovascular diabetic complications, particularly cardiac disease, retinopathy and peripheral arterial disease...
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimeticNadezda Koleganova
Insitute of Pathology, University of Heidelberg, Heidelberg, Germany
Lab Invest 89:520-30. 2009..We conclude that lowering parathyroid hormone with a calcimimetic significantly improves cardiac histology and function but not the left ventricular mass in SNX...
Oxidative stress after uninephrectomy alters heart morphology in the apolipoprotein E -/- mouseGrzegorz Piecha
Department of Internal Medicine, Division of Nephrology, University of Heidelberg, Heidelberg, Germany
J Hypertens 26:2220-9. 2008..The current study on the apolipoprotein E -/- mouse was designed to investigate whether nephron reduction by uninephrectomy causes cardiac remodeling and whether this is prevented by antioxidative treatment...
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat modelJudith Adams
Department of Urology, Ruperto Carola University, Heidelberg, Germany
Nephrol Dial Transplant 17:780-7. 2002..This finding is consistent with the notion that ET(A)-receptor mediated events play a partly BP-independent role in the genesis of CTN. Combination therapy exerts no additive nephroprotection...
Metabolic syndrome and kidney diseaseEberhard Ritz
Ruperto Carola University Heidelberg, Heidelberg, Germany
Blood Purif 26:59-62. 2008..Recent evidence points to adverse effects of aldosterone on podocytes, mediated by reactive oxygen species and resulting from hypothetical stimulants of aldosterone synthesis by visceral adipocytes...
Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patientsOliver Vonend
Department of Nephrology, Heinich Heine University of Duesseldorf, Germany
Semin Dial 21:326-30. 2008..The available experimental and clinical evidence to suggest such a pathophysiological role of sympathetic overactivity is summarized in this current review...
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combinationGrzegorz Piecha
Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
Am J Physiol Renal Physiol 295:F137-44. 2008..Combining the AT1 blocker with mineralocorticoid receptor blockade failed to further increase the regression of glomerulosclerosis...
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetesMarie Luise P Gross
Department of Pathology, University of Heidelberg, Heidelberg, Germany
Lab Invest 86:262-74. 2006..These data suggest that in a model of type II diabetes, the dopamine D3-RA had a beneficial effect on renal morphology and albuminuria, which was comparable in magnitude to that of ACE-i treatment...
Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the ratMatthias Schaier
Department of Nephrology, University Hospital, University of Heidelberg, Bergheimer Strasse 56a, 69115, Heidelberg, Germany
J Mol Med (Berl) 82:116-25. 2004..Receptor-specific retinoids may provide a novel therapeutic approach for the treatment of chronic glomerulonephritis...
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blockerMarie Luise Gross
Departments of Pathology, University of Heidelberg, Heidelberg, Germany
Lab Invest 83:1267-77. 2003..This is particularly the case for podocyte changes pointing to angiotensin II-dependent pathomechanisms...
Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factorsHiroaki Ogata
Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
J Am Soc Nephrol 14:959-67. 2003..Furthermore, it interferes with the development of cardiovascular risk factors and cardiac remodeling...
Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjectsJan T Kielstein
Department of Internal Medicine, Medical School Hannover, Germany
Circulation 107:1891-5. 2003..CONCLUSIONS: These results are compatible with the notion that accumulation of the endogenous NO synthase inhibitor ADMA in senescent individuals is involved in the decrease of renal perfusion and increase of blood pressure...
The clinical management of hyperphosphatemiaEberhard Ritz
Klinikum der Universitat Heidelberg, Heidelberg, Germany
J Nephrol 18:221-8. 2005..In this article, the consequences of hyperphosphatemia are reviewed, and recent developments in the treatment of the condition are discussed...
Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertensionMoriz Buzello
Department of Pathology, University of Heidelberg, Germany
Virchows Arch 442:364-71. 2003..These observations document that experimental renovascular hypertension induces a rapidly developing LVH characterized by marked cardiac remodeling and substantial loss of cadiomyocytes...
Nephron number and renal risk in hypertension and diabetesMarie-Luise Gross
Department of Pathology, Ruprecht-Karl University, Heidelberg, Germany
J Am Soc Nephrol 16:S27-9. 2005..Furthermore, intrauterine programming during organogenesis, e.g., by hyperglycemia, seems to be important: In animal experiments, offspring of either hyperglycemic or diabetic mothers have fewer nephrons...
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristicsChristoph Wanner
Division of Nephrology, University Clinic, Wurzburg, Germany
Kidney Blood Press Res 27:259-66. 2004..The results of the study will provide important information on the efficacy and safety of atorvastatin to support its use in patients with an impaired renal function who are at a high risk of vascular morbidity and mortality...
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized ratsChristian Morath
Department of Nephrology, University of Heidelberg, Im Neuenheimer Feld 162, 69120, Heidelberg, Germany
J Mol Med (Berl) 87:53-64. 2009..We conclude that LD isotretinoin attenuates progressive renal damage, whereas HD isotretinoin cumulates and aggravates renal damage independent of blood pressure reduction...
Pathophysiology of hypertensive renal damageE Ritz
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Am J Hypertens 6:241S-244S. 1993..Several studies have provided encouraging evidence that antihypertensive therapy, particularly with angiotensin-converting enzyme inhibitors or calcium antagonists, can slow the progression of renal damage...
Renal disease and hypertension in non-insulin-dependent diabetes mellitusN Ismail
Department of Internal Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Kidney Int 55:1-28. 1999....
Sympathetic overactivity and arterial hypertension in renal failureS R Orth
Department of Nephrology, Ruperto Carola University Heidelberg, Germany
Nephrol Dial Transplant 16:67-9. 2001..The sequelae of sympathetic overactivity extend beyond their effects on blood pressure and include accelerated progression of renal failure and presumably increased cardiac arrhythmia...
Consequences of late referral in diabetic renal diseaseE Ritz
University of Heidelberg, Department of Internal Medicine, Heidelberg, Germany
Acta Diabetol 39:S3-8. 2002....
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic ratsTobias Odenwald
Department of Pediatrics, University of Heidelberg, Germany
J Am Soc Nephrol 17:655-62. 2006..1+/-4 versus 32.5+/-1.4 mmol/kg; P=0.01). The calcimimetic R-568 causes an initial BP increase in sham-operated and uremic rats, which in uremic rats is followed by a marked and sustained antihypertensive effect...
Cigarette smoke condensate aggravates renal injury in the renal ablation modelGiulio Odoni
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Kidney Int 61:2090-8. 2002..Renal injury induced by cigarette smoke condensate in this model is reversed by renal denervation. We conclude that cigarette smoke-induced renal damage is due, at least in part, to activation of the sympathetic nerve system...
Retinoid receptor-specific agonists alleviate experimental glomerulonephritisIngo Lehrke
Department of Nephrology, University of Heidelberg, 69120 Heidelberg, Germany
Am J Physiol Renal Physiol 282:F741-51. 2002..Further studies are indicated to define the potential use of retinoid agonists in inflammatory renal disease...
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized ratsGrzegorz Piecha
Institute of Pathology, Univ of Heidelberg, Im Neuenheimer Feld 220 221, D 69120 Heidelberg, Germany
Am J Physiol Renal Physiol 294:F748-57. 2008..Calcitriol and R-568 were similarly effective in ameliorating kidney damage...
Late referral--a major cause of poor outcome in the very elderly dialysis patientVedat Schwenger
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Nephrol Dial Transplant 21:962-7. 2006..There is little documentation whether late referral is more frequent in the very elderly (> or =75 years) as compared with non-elderly patients and whether it contributes, at least in part, to their particularly poor outcome...
Cardiovascular complications in the diabetic patient with renal disease: an update in 2003Ralf Dikow
Department of Internal Medicine, University of Heidelberg, Bergheimer Strasse 58, D-69115 Heidelberg, Germany
Nephrol Dial Transplant 18:1993-8. 2003
Arterial calcification in patients with chronic kidney diseaseNadezda Koleganova
Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
Nephrol Dial Transplant 24:2488-96. 2009..The aim of the present study was to characterize aortic calcification in renal compared with non-renal patients...
Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patientsMarie Luise Gross
Institute of Pathology, Heidelberg, Germany
Clin J Am Soc Nephrol 2:121-34. 2007..A more marked inflammatory response in renal patients is suggested by more frequent presence and greater intensity of markers of inflammation...
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease studyBjoern Becker
Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
J Am Soc Nephrol 16:1091-8. 2005..Moreover, hypoadiponectinemia is a novel putative CV risk factor in patients with mild and moderate renal failure...
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysisChristoph Wanner
Division of Nephrology, Department of Medicine, University of Wurzburg, Wurzburg, Germany
N Engl J Med 353:238-48. 2005..However, the benefit of statins in such patients receiving hemodialysis, who are at high risk for cardiovascular disease and death, has not been examined...
Cardiovascular abnormalities and hypertension in the elderly dialysis patientRalf Dikow
Department Internal Medicine, Ruperto Carola University of Heidelberg, Heidelberg, Germany
Semin Dial 15:121-6. 2002..The latter observation has led to an "old for old" program in Europe...
Prenatal causes of kidney diseaseN Koleganova
Ruperto Carola University Heidelberg, Heidelberg, Germany
Blood Purif 27:48-52. 2009..Numerous factors may trigger intra-uterine restriction of fetal growth, such as uterine underperfusion, maternal malnutrition, hyperglycaemia and hyperinsulinaemia of the mother, smoking or medications...
Endothelin in renal diseases and cardiovascular remodeling in renal failureS R Orth
Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany
Intern Med 40:285-91. 2001....
